Poly (D, L-lactide) nanosuspensions of risperidone for parenteral delivery: Formulation and in-vitro evaluation

Current Drug Delivery

Volumn 6, Issue 1, 2009, Pages 62-68

  Muthu, M S ^a   Singh, S ^b  

^a BANARAS HINDU UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Nanoprecipitation method; Poly (D, L lactide) nanoparticles suspensions; Release kinetics; Reverse dialysis technique; Risperidone; Stability study

Indexed keywords

NANOPARTICLE; POLOXAMER; POLYLACTIDE; RISPERIDONE; STABILIZING AGENT;

ARTICLE; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; EQUILIBRIUM DIALYSIS; IN VITRO STUDY; NANOENCAPSULATION; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SUSPENSION;

ANTIPSYCHOTIC AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG STABILITY; INJECTIONS, INTRAVENOUS; NANOPARTICLES; PARTICLE SIZE; POLYESTERS; RISPERIDONE; SOLUBILITY; SURFACE-ACTIVE AGENTS; SUSPENSIONS;

EID: 61849094331     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720109787048302     Document Type: Article

References (30)

1. Gref, R.; Minamitake, Y. Biodegradable long circulating nanospheres. Science, 1994, 263, 1600-3.
2. Labhasetwar, V.; Song, C.; Levy, R.J. Nanoparticles drug delivery systems. Adv. Drug Deliv. Rev., 1997, 24, 63-85.
3. Sinha, V.R.; Bansal, K.; Kaushik, R.; Kumaria, R.; Trehan, A. Poly-epsilon-caprolactone microspheres and nanospheres: an overview. Int. J. Pharm., 2004, 278, 1-23.
4. Allemann, E.; Gurny, R.; Doelker, E. Drug-loaded nanoparticles- preparation methods and drug targeting issues. Eur. J. Pharm. Biopharm., 1993, 39, 173-91.
5. Mainardes, R.M.; Evangelista, R.C. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int. J. Pharm., 2005, 290, 137-44.
6. Wu, P.; Grainger D.W. Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials, 2006, 27, 2450-67.
7. Gaur, U.; Sahoo, S.K.; De, T.K.; Ghosh, P.C.; Maitra, A.; Ghosh, P.K. Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. Int. J. Pharm., 2000, 202, 1-10.
8. Durand, R.; Paul, M.; Rivollet, D.; Fessi, H.; Houin, R.; Astier, A.; Deniau, M. Activity of pentamidine-loaded poly (D,L-lactide) nanoparticles against Leishmania infantum in a murine model. Parasite, 1997, 4, 331-6.
9. Ereshefsky, L.; Lacombe, S. Pharmacological profile of risperidone. Can. J . Psychiatry, 1993, 38, S80-S88.
10. Budavari, S. The Merck Index, Merck & Co., Inc., Whitehouse Station, 2001.
11. Hardman, G.; Limbid, L.E.; Gilman, A.G. The Pharmacological Basis of Therapeutics, McGraw Hill, 2001.
12. Aravagiri, M.; Yuwiler, A.; Marder, S. Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxy-risperidone in the brain and other tissues of rat. Psychopharmacology (Berl.), 1998, 139, 356-63.
13. Ereshefsky, L.; Mascarenas, C.A. Comparison of the effects of different routes of antipsychotic administration on pharmacokinetics and pharmacodynamics. J. Clin. Psychiatry, 2003, 64, 18-23.
14. Pinto Reis, C.; Neufeld, R.J.; Ribeiro, A.J.; Veiga, F. Nanoencapsulation I. Methods for preparation of drug loaded polymeric nanoparticles. Nanomedicine, 2006, 2, 8-21.
15. Singh, S.; Muthu, M.S. Preparation and characterization of nanoparticles containing an atypical antipsychotic agent. Nanomed, 2007, 2, 233-40.
16. Fessi, H.; Puisieux, F.; Devissaguet, JP. Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles. US 5, 118, 528, 1992.
17. Zili, Z.; Sfar, S.; Fessi, H. Preparation and characterization of polyepsilon-caprolactone nanoparticles containing griseofulvin. Int. J. Pharm., 2005, 294, 261-7.
18. Chorny, M.; Fishbein, I.; Danenberg, H.D.; Golomb, G. Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics. J. Control. Release, 2002, 83, 389-400.
19. Moneghini, M.; Voinovich, D.; Princivalle, F.; Magarotto, L. Formulation and Evaluation of Vinylpyrrolidone/Vinylacetate Copolymer Microspheres with Carbamazepine. Pharm. Dev. Technol., 2000, 5, 347-53.
20. Verger, M.L.; Fluckiger, L.; Kim, YI.; Hoffman, M.; Maincent, P. Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur. J. Pharm. Biopharm., 1998, 46, 137-43.
21. Yang, S.C.; Lu, L.F.; Cai, Y.; Zhu, J.B.; Liang, B.W.; Yang, C.Z. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J. Control. Release, 1999, 59, 299-307.
22. Fessi, H.; Puisieux, F.; Devissaguet, J.P.; Ammoury, N.; Benita, S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm., 1989, 55, R1-R4.
23. Betancourt, T.; Brown, B.; Brannon-peppas, L. Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation. Nanomed, 2007, 2, 219-32.
24. Shenoy, D.B.; Amiji, M.M. Poly (ethylene oxide)-modified poly (epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. Int. J. Pharm., 2005, 293, 261-70.
25. Kreuter, J. Nanoparticles and microparticles for drug and vaccine delivery. J. Anat., 1996, 189, 503-5.
26. Govender, T.; Riley, T.; Ehtezazi, T.; Garnett, M.C.; Stolnik, S.; Illum, L.; Davis, S.S. Defining the drug incorporation properties of PLA-PEG nanoparticles. Int. J. Pharm., 2000, 199, 95-110.
27. Brigger, I.; Dubernet, C.; Couvreur, P. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev., 2002, 54, 631-51.
28. Higuchi, W.I. Mechanism of sustained action medication. J. Pharm. Sci., 1962, 51, 802-4.
29. Mehta, A.K.; Yadav, K.S.; Sawant, K.K. Nimodipine loaded PLGA nanoparticles: formulation optimization using factorial design, characterization and in vitro evaluation. Curr. Drug Deliv., 2007, 4, 185-93.
30. Korsmeyer, R.W.; Gurney, R.; Doelker, E.; Buri, P.; Peppas, N.A. Mechanism of solute release from porous hydrophilic polymer. J. Pharm. Sci., 1983, 15, 25-35.